Synthesis and resolution of 2-arylalkyl-2-(tetrazol-5-yl)-N-arylalkyl-carboxamides. A new class of chiral sterically hindered tetrazole derivatives

Chiral, racemic 2-arylalkyl-2-(tetrazol-5-yl)-N-arylalkylcarboxamides 3 were conveniently prepared from ethyl cyanoacetate in four steps. The synthetic methodology developed is a facile way of introducing bulky substituents into a peptide-like framework, affording intermediate α-arylalkyl-α-amidonitriles. These nitriles were sufficiently activated to give, upon treatment with ammonium azide in dimethylformamide at 145° for twenty-four to thirty hours, the corresponding tetrazoles in good yields. It has been determined that an optically pure α-arylalkyl-α-amidonitrile epimerized to give diastereomeric products under the above conditions. A procedure for the fractional crystallization of the (S)-(-)-α-methylbenzylamine salts 4 of the tetrazoles to give the optically enriched tetrazoles 5 was also developed.     

Synthesis of 6H-pyrrolo[3',4':2,3][1,4]diazepino[6,7,1-hi]indole-8,10(7H,9H)-diones using 3-bromo-4-(indol-1-yl)maleimide scaffold

Series of 3-arylalkyl- or 3-alkylamino-4-(indol-1-yl)maleimides and bis(indol-1-yl)maleimides were synthesised. The cyclization of the 3-substituted 4-(indol-1-yl)maleimides under the action of acids resulted in the formation of diazepine[1,4] derivatives with indoline and maleimide nuclei annelated. These compounds readily produced the corresponding indolomaleimidodiazepines[1,4] after dehydrogenation.     

Synthesis of symmetrical α-alkyl- and α-arylalkylbenzyl and diarylmethyl ethers by HCl-catalyzed intermolecular dehydration

α-Alkyl-, α-arylalkyl-, and α-aryl-substituted benzyl alcohols were converted into the corresponding symmetrical dibenzyl ethers in the presence of a catalytic amount of 10% aqueous HCl both in methylene chloride and under solvent-free conditions. Analogous reactions in dioxane and on heating afforded mainly the corresponding arylalkenes, whereas symmetrical dibenzyl ethers were formed as minor products.     

Stereoselective first total synthesis of (R)-rugulactone

A simple and highly efficient stereoselective synthetic route has been developed for the synthesis of (R)-rugulactone, a 6-arylalkyl-5,6-dihydro-2H-pyran-2-one, from readily available substrates such as 1,3-propanediol and 3-phenyl-1-propanal employing Keck’s asymmetric allylation and cross metathesis as key steps.     

Stepwise bromination of two acetylene molecules on a butterfly-type tetrairon core and reactivity of the resulting bromoacetylene fragment toward nucleophiles

Treatment of the acetylene-coordinated tetrairon cluster, [(eta5-C5H4Me)4Fe4(HCCH)2]+, with N-bromosuccinimide led to stepwise bromination of two acetylene ligands to form [(eta5-C5H4Me)4Fe4(HCCBr)(HCCH)]+, [(eta5-C5H4Me)4Fe4(HCCBr)2]+, [(eta5-C5H4Me)4Fe4(BrCCBr)(HCCBr)]+, and [(eta5-C5H4Me)4Fe4(BrCCBr)2]+. The reactivity of the bromoacetylene fragment in [(eta5-C5H4Me)4Fe4(HCCBr)(HCCH)]+ toward water, pyridine, and ZnMe2 was also investigated.     

Epoxidation of propyl- and isobutyl-β-alkylvinylketones

A study is made of the epoxidation of hepten-2-one-4, octen-3-one-5, nonen-4-one-6, 2-methylhepten-5-one-4, 2-methylocten-5-one-4, and 2-methylnonen-5-one-4 with alkaline methanolic hydrogen peroxide. 46–71% yield of the corresponding epoxy ketones are obtained. It is shown that treatment of the 2, 3-epoxyheptanone-4, 3, 4-epoxyoctanone-5, 4, 5-epoxynonanone-6, 2-methyl-5, 6-epoxyheptanone-4, 2-methyl-5, 6-epoxyoctanone-4 and 2-methyl-5, 6-epoxynonanone-4 with zinc chloride isomerizes them to, respectively, heptandione-3, 4, octandione-4, 5, nonandione-4, 5, 2-methylheptandione-4, 5, 2-methyloctandione-4, 5, and 2-methylnonandione-4, 5 in upto 78% yield.     

Synthesis and Bioassay of Novel Substituted Pyrano[2,3‐f]cinnoline‐2‐ones

A new series of 9‐substituted‐4,10‐dimethylpyrano[2,3‐f]cinnolin‐2‐ones ( 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j , 5k , 5l , 5m ) were synthesized via intramolecular cyclization of the respective acyl amidrazone derivatives ( 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j , 4k , 4l , 4m ), catalyzed by polyphosphoric acid. Compounds ( 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j , 4k , 4l , 4m ) were synthesized through direct interaction of coumarin‐7‐yl hydrazonoyl chloride ( 3 ) with the corresponding cyclic sec‐amines in the presence of triethylamine. The structures of the new compounds were confirmed by elemental analyses, NMR, and MS spectral data. The antitumor activity of compounds 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j , 5k , 5l , 5m was evaluated in vitro on breast cancer cell line (MCF‐7) by a cell viability assay utilizing the tetrazolium dye 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide. Among the compounds tested, compounds 5d , 5f , 5k , and 5h showed potential anti‐MCF‐7 activity and were able to reduce the viability after 72 h to less than 50%.     

Ring transformation of 5-acylpyrimidines into 4-acylpyrazoles with hydrazine and phenylhydrazine in acidic medium

5-Benzoyl-4-methylpyrimidines 4a,b and 5-acetyl-4-phenylpyrimidines 5a,b reacted with hydrazines in alcoholic acidic medium to give respectively 4-acetyl-3-phenylpyrazoles 7, 9 and 10 and 4-benzoyl-3-methylpyrazoles 6, 8 and 11 . In the reaction with phenylhydrazine, 5-benzoyl-4-methyl-2-methylthiopyrimidine ( 4a ) led exclusively to 4-acetyl-1,3-diphenylpyrazole ( 10 ) as 5-acetyl4-phenyl-2-methylthiopyrimidine ( 5a ) led to 4-benzoyl-3-methyl-1-phenylpyrazole ( 11 ) via the initial formation of phenylhydrazones of pyrimidines 4a and 5a . However, 5-benzoyl-4-methyl-2-phenylpyrimidine ( 4b ) and 5-acetyl-2,4-diphenylpyrimidine ( 5b ) reacted with phenylhydrazine to afford, each of them, a mixture of two isomeric pyrazoles. The mechanism of these ring contraction reactions is discussed.     

Facile syntheses of unsolvated UI3 and tetramethylcyclopentadienyl uranium halides

In the course of comparing the reaction chemistry of (C5Me5)3U, 1, and its slightly less crowded analogue (C5Me4H)3U, 2, new syntheses of UI3, (C5Me4H)3U, (C5Me4H)3UCl, 3, and (C5Me5)3UCl, 4, have been developed. Additionally, (C5Me4H)3UI, 5, and (C5Me4H)2UCl2, 6, have been identified for the first time. A facile synthesis of unsolvated UI3 is reported that proceeds in high yield with inexpensive equipment from iodine and hot uranium turnings. Both UI3 and UI3(THF)4 react with KC5Me4H in toluene to make unsolvated (C5Me4H)3U in higher yield than in previous reports that involve reduction of tetravalent (C5Me4H)3UCl, 3. A more atom-efficient synthesis of complex 3 is also reported that proceeds from reduction of t-BuCl, PhCl, or HgCl2 by 2. Similarly, (C5Me4H)3U reacts with PhI or HgI2 to generate (C5Me4H)3UI. These studies also provided a basis to improve the synthesis of (C5Me5)3UCl from 1 by employing t-BuCl or HgCl2 as the halide source. Like (C5Me5)3UCl, the (C5Me4H)3UCl complex reacts with HgCl2 to form (C5Me4H)2 and (C5Me4H)2UCl2, 6, but unlike (C5Me5)3UX (X = Cl or I), the less substituted (C5Me4H)3UX complexes do not reduce t-BuCl or PhX. The synthesis of 6 from (C5Me4H)MgCl x THF and UCl4 is also included.     

Zur Synthese sulfonierter Derivate von 4- und 5-Aminoindan

On the Synthesis of Sulfonated Derivatives of 4- and 5-Aminoindan Baking the hydrogensulfate salt of 4-aminoindan (1) and 5-aminoindan (2) led, respectively, to 4-aminoindan-7-sulfonic acid (3) and 5-aminoindan-6-sulfonic acid (4). Acid 4 was also obtained by direct sulfonation of 2. 4-Aminoindan-6-sulfonic acid (5) and 6-aminoindan-4-sulfonic acid (6) were prepared by sulfonation of 4-nitroindan (7) and 5-nitroindan (9) , respectively, to 4-nitroindan-6-sulfonic acid (8) and 6-nitroindan-4-sulfonic acid (10) , followed by a Béchamp-reduction. Treatment of 1 with amidosulfuric acid gave 3 , whereas the same reaction with 2 led to a mixture of 4 and 5-aminoindan-4-sulfonic acid (11). Independent synthesis of 11 was achieved by the following sequence of reactions: sulfur dioxide treatment of the diazonium chloride derived from 4-amino-5-nitrodan (13) gave 5-nitroindan-4-sulfonyl chloride (14) ; hydrolysis to 5-nitroindan-4-sulfonic acid (15) , and final reduction. The 4-aminoindan-5-sulfonic acid (16) was synthesized by treatment of 4-amino-7-bromoindan (18) with amidosulfuric acid to give 4-amino-7-bromoindan-5-sulfonic acid (19) followed by hydrogenolysis. Sulfonation of 4-acetyl-amino-7-bromoindan (17) with oleum followed by hydrolysis led to 7-amino-4-bromoindan-5-sulfonic acid (20) , the structure of which was confirmed by reductive dehalogenation to 5 .     

过渡金属μ3-E立方烷簇合物(η ^5-C5H5)4Fe4(μ3-Se)4及 (η ^5-RC5H4) 4Cr4(μ3-S)4的合成与表征

通过 (η5 C5H5) 2 Fe2 (CO) 4和硒粉在沸腾的甲苯中反应可制得含 μ3 Se的立方烷簇合物 (η5 C5H5) 4Fe4 (μ3 Se) 4(1) ,而由 (η5 RC5H4 ) 2 Cr2 (CO) 4S在甲苯中回流可制得含 μ3 S的立方烷簇合物 (η5 RC5H4 ) 4Cr4 (μ3 S) 4(2 ,R =COMe ;3,R =CO2 Me)。企图通过 (η5 EtO2 CC5H4 ) 2 Fe2 (CO) 4(5 )和硫黄制备 μ3 S立方烷簇合物 (η5 EtO2 CC5H4 ) 4Fe4 (μ3 S) 4(6 )未获成功 ,其中 5是由 η5 EtO2 CC5H4 Fe(CO) 2 Na与 η5 EtO2 CC5H4 Fe(CO) 2 I (4 )缩合制得。新化合物 1～ 5经元素分析 ,IR和1 HNMR光谱表征     

Synthesis of analogs of 5(4)-aminoimidazole-4(5)-carboxamide

In order to obtain 5(4)-aminoimidazole-4(5)carboxamide antagonists, the.hydrazides of 5(4)-aminoimidazole-4(5)-carboxylic acid and 5(4)-aminoimidazole-4(5)hydroxamic acid were synthesized, and the reaction of 5(4)-bromo-4(5)sulfamoylimidazole with amines was studied.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 10, pp. 1421–1422, October, 1971.     

Synthesis of analogs of 5(4)-aminoimidazole-4(5)-caeboxamide and purines

4(5)-Sulfonyl chlorides, which were converted to the corresponding sulfamoyl derivatives, were obtained from the amide and ethyl ester of 4(5)-mercaptoimidazole-5(4)-carboxylic acid by oxidative chlorination. The azide of 4(5)-sulfamoylimidazole-5(4)carboxylic acid was synthesized through 4(5)-sulfamoylimidazole-5(4)-carboxylhydrazide, and its conversion in various media to 5(4)-aminoimidazole-4(5)-sulfonamide derivatives and to 3,4-dihydro-3-oxoimidazo[4,5-e]-1,2,4-thiadiazine 1,1-dioxide was studied.See [1] for communication V.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 8, pp. 1119–1122, August, 1976.     

Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor

The considerable interest in substituted isoquinolin-1-ones related to 5-aminoisoquinolin-1-one (5-AIQ) as drugs points to a need for an efficient and straightforward synthesis of the 4,5-disubstituted bicycles. Bromination of 5-nitroisoquinolin-1-one gave 4-bromo-5-nitroisoquinolin-1-one but neither this nor 5-amino-4-bromoisoquinolin-1-one would participate in Pd-catalysed couplings. Protection of the lactam as 1-methoxy- and 1-benzyloxy-4-bromo-5-nitroisoquinolines, however, permitted Stille, Suzuki and Buchwald-Hartwig couplings to take place in high yields, insensitive to electronic demands and severe steric bulk in the arylboronic acids. Lithiation of 4-bromo-1-methoxy-5-nitroisoquinoline and quench with iodomethane gave 1-methoxy-4-methyl-5-nitroisoquinoline in low yield. Demethylation of the 1-methoxy-4-substituted-5-nitroisoquinolines with hydrogen bromide gave 4-substituted-5-nitroisoquinolin-1-ones, whereas hydrogenolytic debenzylation was achieved with simultaneous reduction of the 5-nitro group. 5-Amino-4-(4-trifluoromethylphenyl)isoquinolin-1-one was identified as a new potent and selective inhibitor of poly(ADP-ribose)polymerase-2 (PARP-2).     

Synthesis and biological evaluation of 5-substituted-4-nitroimidazole ribonucleosides

The imidazole nucleosides, 4(5)-bromo-5(4)-nitro-1-β-D-ribofuranosylimidazoles, have been prepared via glycosylation of the trimethylsilylated aglycone, 4(5)-bromo-5(4)-nitroimidazole, with tetra-O-acetyl-β-D-ribo-furanose followed by removal of the acetyl protecting groups. The 5-bromo-4-nitro-1-β-D-ribofuranosylimidazole nucleoside was acetonated to produce 5-bromo-4-nitro-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-imidazole which was cyclized to provide the corresponding anhydronucleoside 5,5′-anhydro-4-nitro-5-oxo-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole. Sodium hydrosulfide treatment of 5-bromo-4-nitroimidazole nucleoside provided 5-mercapto-4-nitro-1-β-D-ribofuranosylimidazole 5-sodium salt which was alkylated with E-1,5-diiodopent-1-ene to yield 5-(E-1-iodo-1-penten-5-yl)thio-4-nitro-1-β-D-ribofuranosylimidazole. The corresponding iodine-125-labeled compound was prepared similarly using radiolabeled diiodopentene. The 5-bromo-4-nitroimidazole, 5-mercapto-4-nitroimidazole, and 5-iodopentenylthio-4-nitroimidazole nucleosides were cytotoxic to Molt-3 cells in vitro at concentrations higher than 10 μg/mL. The radiolabeled 5-iodopentenylthio-4-nitroimidazole nucleoside showed 2-fold higher uptake in a rapidly growing tumor as compared to uptake in a relatively slower growing tumor in mice.     

Synthesis and In Vitro Antimicrobial Screening of New Azetidin‐2‐ones of 5‐Ethyl Pyridine‐2‐ethanol

A new series of azetidinones is described in this paper; Schiff base ( 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j , 4k , 4l , 4m , 4n , 4o ) were synthesized from 4‐[2‐(5‐ethylpyridin‐2‐yl)ethoxy]benzaldehyde, which was used to synthesize azetidinones ( 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j , 5k , 5l , 5m , 5n , 5o ), ( 6a , 6b , 6c , 6d , 6e , 6f , 6g , 6h , 6i , 6j , 6k , 6l , 6m , 6n , 6o ), and ( 7a , 7b , 7c , 7d , 7e , 7f , 7g , 7h , 7i , 7j , 7k , 7l , 7m , 7n , 7o ). The structures of the synthesized compounds were assigned on the basis of elemental analysis, IR, ¹H NMR, and ¹³C NMR spectral data. All the products were screened against different strains of bacteria and fungi. Most of the monosubstituted and disubstituted chloro groups are more effective to both bacterial and fungal species in comparison with the standard drugs.     

Strain-controlled, photochemically, or thermally promoted haptotropic shifts of cyclopentadienyl ligands in group 8 metallocenophanes

Cyclopentadienyl (Cp) ligands in moderately strained [1]- and [2]ferrocenophanes [Fe{(eta5-C5H4)2(ERx)y}: Fe{(eta5-C5H4)2SiMe2} (1), Fe{(eta5-C5H4)CH2}2 (10)] and highly strained [2]ruthenocenophanes [Ru{(eta5-C5H4)CR2}2 {R = H (15), Me (16)}] are susceptible to partial substitution by P donors and form mixed-hapticity metallocycles-[M(L2){(eta5-C5H4)(ERx)y(eta1-C5H4)}]: [Fe(dppe){(eta5-C5H4)SiMe2(eta1-C5H4)}] (5), [Fe(dmpe){(eta5-C5H4)SiMe2(eta1-C5H4)}] (6), [Fe(dmpe){(eta5-C5H4)(CH2)2(eta1-C5H4)}] (11), [Ru(dmpe){(eta5-C5H4)(CH2)2(eta1-C5H4)}] (17), [Ru(dmpe){(eta5-C5H4)(CMe2)2(eta1-C5H4)}] (18), and [Ru(PMe3)2{(eta5-C5H4)(CH2)2(eta1-C5H4)}] (19)-through haptotropic reduction of one eta5-, pi-bound Cp to eta1, sigma-coordination. These reactions are strain-controlled, as highly ring-tilted [2]ruthenocenophanes 15 and 16 [tilt angles (alpha) approximately 29-31 degrees ] react without irradiation to form thermodynamically stable products, while moderately strained [n]ferrocenophanes 1 and 10 (alpha approximately 19-22 degrees ) require photoactivation. The iron-containing photoproducts 5 and 11 are metastable and thermally retroconvert to their strained precursors and free phosphines at 70 degrees C. In contrast, the unprecedented ring-opening polymerization (ROP) of the essentially ring-strain-free adduct 6 to afford poly(ferrocenyldimethylsilane) [Fe(eta5-C5H4)2SiMe2]n (Mw approximately 5000 Da) was initiated by the thermal liberation of small amounts of P donor. Unlike reactions with bidentate analogues, monodentate phosphines promoted photolytic ROP of ferrocenophanes 1 and 10. MALDI-TOF analysis suggested a cyclic structure for the soluble poly(ferrocenyldimethylsilane), 8-cyclic, produced from 1 in this manner. While the polymer likewise produced from 10 was insoluble, the initiation step in the ROP process was modeled by isolation of a tris(phosphine)-substituted ring-opened ferrocenophane [Fe(PMe3)3{(eta5-C5H4)(CH2)2(C5H5)}][OCH2CH3] (13[OCH2CH3]) generated by irradiation of 10 and PMe3 in a protic solvent (EtOH). Studies of the cation 13 revealed that the Fe center reacts with a Cp- anion with loss of the phosphines to form [Fe(eta5-C5H5){(eta5-C5H4)(CH2)2(C5H5)}] (14) under conditions identical to those of the ROP experiments, confirming the likelihood of "back-biting" reactions to yield cyclic structures or macrocondensation to produce longer chains.     

Novel dimetal bridging carbene complexes derived from a terminal carbonyl dimetal compound. Syntheses, structures and reactivities of 7H-indene-coordinated diiron bridging carbene complexes

Pentacarbonyl-7H-indenediiron, [Fe2(CO)5(eta3,eta5-C9H8)] (1), reacts with aryllithium, ArLi (Ar = C6H5, p-C6H5C6H4), followed by alkylation with Et3OBF4 to give novel 7H-indene-coordinated diiron bridging alkoxycarbene complexes [Fe2{mu-C(OC2H5)Ar}(CO)4(eta4,eta4-C9H8)] (2, Ar = C6H5; 3, Ar = p-C6H5C6H4). Complexes 2 and 3 react with HBF4.Et2O at low temperature to yield cationic bridging carbyne complexes [Fe2(mu-CAr)(CO)4(eta4,eta4-C9H8)]BF4 (4, Ar = C6H5; 5, Ar = p-C6H5C6H4). Cationic 4 and 5 react with NaBH4 in THF at low temperature to afford diiron bridging arylcarbene complexes [Fe2{mu-C(H)Ar}(CO)4(eta4,eta4-C9H8)] (6, Ar = C6H5; 7, Ar = p-C6H5C6H4). The similar reactions of 4 and 5 with NaSC6H4CH3-p produce the bridging arylthiocarbene complexes [Fe2{mu-C(Ar)SC6H4CH3-p}(CO)4(eta4,eta4-C9H8)] (8, Ar = C6H5; 9, Ar = p-C6H5C6H4). Cationic 4 and 5 can also react with anionic carbonylmetal compounds Na[M(CO)5(CN)] (M = Cr, Mo, W) to give the diiron bridging aryl(pentacarbonylcyanometal)carbene complexes [Fe2{mu-C(Ar)NCM(CO)5}(CO)4(eta4,eta4-C9H8)] (10, Ar = C6H5, M = Cr; 11, Ar = p-C6H5C6H4, M = Cr; 12, Ar = C6H5, M = Mo; 13, Ar = p-C6H5C6H4, M = Mo; 14, Ar = C6H5, M = W; 15, Ar = p-C6H5C6H4, M = W). Interestingly, in CH2Cl2 solution at room temperature complexes 10-15 were transformed into the isomerized 7H-indene-coordinated monoiron complexes [Fe(CO)2(eta5-C9H8)C(Ar)NCM(CO)5] (16, Ar = C6H5, M = Cr; 17, Ar = p-C6H5C6H4, M = Cr; 18, Ar = C6H5, M = Mo; 19, Ar = p-C6H5C6H4, M = Mo; 20, Ar = C6H5, M = W; 21, Ar = p-C6H5C6H4, M = W), while complex 3 was converted into a novel ring addition product [Fe2{C(OC2H5)C6H4C6H5-p-(eta2,eta5-C9H8)}(CO)5] (22) under the same conditions. The structures of complexes 2, 6, 8, 14, 18 and 22 have been established by X-ray diffraction studies.     

Substituted pyridines

2, 5-Dimethylpiperidol-4, 1, 2, 5-trimethylpiperidol-4, and the gamma isomer of 1, 2, 5-trimethyl-4-phenylpiperidol-4 are dehydrated by various methods. The secondary piperidols mentioned are used to synthesize 5-methyl-2-formylpyridine and 5-methyl-4-phenyl-2-formylpyridine.     

Synthesis and Antimicrobial Screening of Some Novel Chromones and Pyrazoles with Incorporated Isoxazole Moieties

The title compounds 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h and 6a , 6b , 6c , 6d , 6e , 6f , 6g , 6h have been synthesized from β‐diketones and chromones, respectively, having 5‐methyl‐3‐phenylisoxazole moiety. Substituted 2‐acetylphenyl 5‐methyl‐3‐phenylisoxazole‐4‐carboxylate 3a , 3b , 3c , 3d , 3e , 3f , 3g , 3h were converted into 1‐(2‐hydroxyphenyl)‐3‐(5‐methyl‐3‐phenylisoxazole‐4‐yl)propane‐1,3‐dione 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h by Baker–Venketaraman transformation. Further, the cyclodehydration of diketone 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h with glacial acetic acid in conc. HCl at reflux gave corresponding substituted 2‐(5‐methyl‐3‐phenylisoxazole‐4‐yl)‐4H‐chromen‐4‐one 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h . The corresponding 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h react with hydrazine hydrate in presence of glacial acetic acid in ethanol at reflux to furnish 2‐(5‐5(5‐methyl‐3‐phenylisoxazole‐4‐yl)‐1H‐pyrazole‐3‐yl)phenol 6a , 6b , 6c , 6d , 6e , 6f , 6g , 6h . The structures of all newly synthesized compounds have been confirmed by IR, ¹H NMR, mass spectral data, as well as elemental analysis. The synthesized compounds have been screened for their antimicrobial activity. Some of the compounds show better antimicrobial activity as compared with the reference drugs Streptomycin, Ampicillin, Gentamycin, Cefixime, and Ketoconazole.